Showing results (671-680 of 829) with videos related to
Sort By:
Pageof 83
Nucleic Acids Research|November 6, 2018
Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humansJarny Choi, Tracey M Baldwin, Mae Wong, et al.Endocrinology|May 8, 2021
A Novel Mouse Model for SNP in Steroid Receptor Co-Activator-1 Reveals Role in Bone Density and Breast Cancer MetastasisRebecca J Watters, Kostas Verdelis, Peter C Lucas, et al.Journal of Medicinal Chemistry|February 14, 2014
Using ovality to predict nonmutagenic, orally efficacious pyridazine amides as cell specific spleen tyrosine kinase inhibitorsMatthew C Lucas, Niala Bhagirath, Eric Chiao, et al.JAMA Oncology|March 28, 2024
Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 TrialsAranzazu Fernandez-Martinez, Mattia Rediti, Gong Tang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2024
Machine Learning Predicts Oxaliplatin Benefit in Early Colon CancerLujia Chen, Ying Wang, Chunhui Cai, et al.Journal of Medicinal Chemistry|March 21, 2024
Optimization of Potent Ligands for the E3 Ligase DCAF15 and Evaluation of Their Use in Heterobifunctional DegradersSimon C C Lucas, Afshan Ahmed, S Neha Ashraf, et al.Hypertension (Dallas, Tex. : 1979)|September 4, 2014
Bcl10 mediates angiotensin II-induced cardiac damage and electrical remodelingLajos Markó, Norbert Henke, Joon-Keun Park, et al.NPJ Breast Cancer|July 3, 2019
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtypeKevin M Levine, Nolan Priedigkeit, Ahmed Basudan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 TrialPriya Rastogi, Hanna Bandos, Peter C Lucas, et al.Breast Cancer Research : BCR|April 22, 2024
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancerSamuel A Jacobs, Ying Wang, Jame Abraham, et al.Pageof 83